- You can view the full Pfizer Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
The vote on repealing and replacing Obamacare has been pulled from the House floor.
Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.
Obamacare? Trumpcare? These stocks don't care.